Signature p53 mutation at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers.
A combination of psoralen and ultraviolet A radiation (PUVA) is widely used in the treatment of psoriasis. However, PUVA treatment increases the risk of developing skin cancer in psoriasis patients and induces skin cancer in mice. Since the DNA damage induced by PUVA is quite different from that induced by UV, we investigated whether PUVA-induced mouse skin cancers display carcinogen-specific mutations in the p53 tumor suppressor gene. The results indicated that 10 of 13 (77%) PUVA-induced skin tumors contained missense mutations predominantly at exons 6 and 7. In contrast, tumor-adjacent, PUVA-exposed skin from tumor-bearing animals did not exhibit p53 mutation in exons 4-8. Interestingly, about 40% of all mutations in PUVA-induced skin tumors occurred at 5'-TA sites, and an equal number of mutations occurred at one base flanking 5'TA or 5'-TAT sites. Since PUVA induces DNA cross-links exclusively at these sites and since UV "signature" mutations were rarely detected in PUVA-induced skin cancers, we can conclude that PUVA acts as a carcinogen by inducing unique PUVA signature mutations in p53. This finding may have implications for identifying the etiology of skin cancer in psoriasis patients who have undergone PUVA therapy.
Nataraj
A J
AJ
Department of Immunology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Black
H S
HS
Ananthaswamy
H N
HN
D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D002273:Carcinogens / Q000633:toxicity*; D003062:Codon / Q000235:genetics; D003432:Cross-Linking Reagents; D004249:DNA Damage; D016158:Genes, p53 / Q000187:drug effects / Q000528:radiation effects; D008730:Methoxsalen / Q000633:toxicity*; D051379:Mice; D008812:Mice, Hairless; D016296:Mutagenesis / Q000187:drug effects / Q000528:radiation effects; D009381:Neoplasms, Radiation-Induced / Q000235:genetics*; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D018807:Polymorphism, Single-Stranded Conformational; D012867:Skin / Q000187:drug effects / Q000473:pathology* / Q000528:radiation effects; D012878:Skin Neoplasms / Q000139:chemically induced / Q000235:genetics*; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis / Q000737:chemistry; D014466:Ultraviolet Rays
D002273:Carcinogens; D003062:Codon; D003432:Cross-Linking Reagents; D016159:Tumor Suppressor Protein p53; D008730:Methoxsalen